Analysis of Eye Tissue
NCT00001224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2008-03-04
Summary
The purpose of this investigation is to better understand the inflammatory process that occurs in uveitis (eye inflammation) through study of eye tissues.
Patients with uveitis sometimes develop cataracts (clouding of the lens of the eye) or clouding of the vitreous-the gel-like material behind the lens-that can impair eyesight. Those who require cataract surgery or vitrectomy are eligible for this study. Samples of eye tissue and fluid normally removed during standard surgical procedures for these conditions will be given to researchers instead of discarded, as is usually done.
Before surgery, patients will undergo routine preoperative tests, including chest X-ray, electrocardiogram, blood tests and urinalysis. They will also have an eye examination and photographs taken of the retina. Other tests that may be performed include fluorescein angiography to evaluate the blood vessels of the retina; ultrasound to examine the back of the eye; and a gallium scan to evaluate inflammation.
Immune cells in the blood and eye tissue will be compared and categorized by disease. The eye fluid will be examined for substances involved in the inflammatory process. These studies may provide information that will lead to improved methods of diagnosis and treatment.
Conditions
- Eye Disease
- Inflammation
- Uveitis
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1987-07-31
- Completion
- 2002-09-30
Countries
- United States
Study Locations
More Related Trials
-
Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis
NCT05388838 ·Status: RECRUITING ·Phase: NA
-
Screening for NEI Clinical Studies
NCT00001734 ·Status: COMPLETED
-
Microbiome as a ThErapeutic Response Biomarker
NCT04721743 ·Status: WITHDRAWN
-
Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
NCT06821971 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
NCT00605943 ·Status: COMPLETED
-
Leflunomide to Treat Uveitis
NCT00001863 ·Status: COMPLETED ·Phase: PHASE2
-
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
NCT02656381 ·Status: COMPLETED
-
Screening for Research Subjects With Anterior Segment Diseases
NCT00088348 ·Status: COMPLETED
-
Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study
NCT01164085 ·Status: COMPLETED ·Phase: PHASE1
-
Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
NCT02879084 ·Status: COMPLETED
-
Daclizumab and Sirolimus to Treat Uveitis
NCT00078689 ·Status: COMPLETED ·Phase: PHASE1
-
The Cohort Study of Uveitis Patients
NCT05727540 ·Status: RECRUITING
-
Uveitis Gene-Expression Profiling
NCT00874471 ·Status: COMPLETED
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial of Infliximab for Uveitis
NCT00273390 ·Status: COMPLETED ·Phase: NA
-
Incidence of Macular Edema in a Uveitis Population
NCT06686641 ·Status: ACTIVE_NOT_RECRUITING
-
Infliximab to Treat Non-Infectious Scleritis
NCT00075075 ·Status: COMPLETED ·Phase: PHASE1
-
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
NCT00943982 ·Status: COMPLETED ·Phase: PHASE1
-
Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD
NCT02218177 ·Status: COMPLETED
-
Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada Disease
NCT05349747 ·Status: UNKNOWN
-
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
NCT05385757 ·Status: ACTIVE_NOT_RECRUITING
-
ANTI-TAC THERAPY FOR UVEITIS
NCT00001526 ·Status: COMPLETED ·Phase: PHASE1
-
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
NCT00876434 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
NCT01162070 ·Status: COMPLETED ·Phase: NA
-
Sirolimus Injections for Autoimmune Scleritis
NCT01517074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2